Indications and uses
Helps prevent infection in • minor cuts • scrapes • burns
Helps prevent infection in • minor cuts • scrapes • burns
• clean affected area • apply a small amount (equal to the surface area of the tip of a finger) on the area 1 to 3 times daily • may be covered with a sterile bandage • Store at controlled room temperature 59º - 86ºF (15º - 30ºC). • Protect from freezing.
(in each gram)
Bacitracin zinc, USP 400 units
Neomycin sulfate, USP 3.5 mg
Polymyxin B sulfate, USP 5,000 units
First aid antibiotic
Helps prevent infection in
For external use only
Allergy alert:
If swallowed, get medical help or contact a Poison Control Center right away.
White petrolatum
1-800-432-8534 between 9 am and 4 pm EST, Monday – Friday.
NDC 63187-039-01
Triple Antibiotic Ointment
FIRST AID ANTIBIOTIC
(Bacitracin Zinc-Neomycin Sulfate-Polymyxin B Sulfate Ointment)
First Aid to Help Prevent Infection in Minor Cuts, Scrapes and Burns
Compare to the active ingredients in Neosporin®*
NET WT 1 OZ (28 g)
*This product is not affiliated with, manufactured by, or produced by the makers of Neosporin®.
Distributed by:
Actavis Pharma, Inc.
Parsippany, NJ 07054 USA
Made in India
Relabeled by:
Proficient Rx LP
Thousand Oaks, CA 91320

| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63187-039-01 | GM - Gram | 63187-039 | 6e600ee6-c2d2-4e37-acd7-ae6acd16b18c | 1 | 2017-06-15 |
| 63187-039-15 | GM - Gram | 63187-039 | f85fc1c4-7ca0-4edf-9381-e850c94da2cc | 1 | 2016-04-04 |
| 0472-0179-34 | GM - Gram | 0472-0179 | f4ba8432-cf28-4d7e-86d8-ad3eaf115bdd | 1 | 2012-07-24 |
| 0472-0179-56 | GM - Gram | 0472-0179 | 02c98cec-6f68-468d-bf85-8c881eb854a2 | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| BACITRACIN ZINC | ACTIVE INGREDIENT | 89Y4M234ES | 1 | |
| NEOMYCIN SULFATE | ACTIVE INGREDIENT | 057Y626693 | 1 | |
| POLYMYXIN B SULFATE | ACTIVE INGREDIENT | 19371312D4 | 1 | |
| BACITRACIN | ACTIVE MOIETY | 58H6RWO52I | 1 | |
| NEOMYCIN | ACTIVE MOIETY | I16QD7X297 | 1 | |
| POLYMYXIN B | ACTIVE MOIETY | J2VZ07J96K | 1 | |
| PETROLATUM | INACTIVE INGREDIENT | 4T6H12BN9U | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63187-039 | 63187-039-15, 63187-039-01 |
| 0472-0179 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BACITRACIN ZINC | 89Y4M234ES | ACTIM |
| NEOMYCIN SULFATE | 057Y626693 | ACTIM |
| POLYMYXIN B SULFATE | 19371312D4 | ACTIM |
| PETROLATUM | 4T6H12BN9U | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / AURICULAR (OTIC) | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CAPSULE / VAGINAL | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SPONGE / TOPICAL | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | TABLET, EXTENDED RELEASE / ORAL | 0.18 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / VAGINAL | 4084 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CREAM, AUGMENTED / TOPICAL | 26 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | LIQUID / RESPIRATORY (INHALATION) | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SUPPOSITORY / VAGINAL | 27 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | AEROSOL, FOAM / TOPICAL | 7.9 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / OPHTHALMIC | 88.4 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | TABLET / ORAL | 3.5 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CAPSULE, EXTENDED RELEASE / ORAL | 0.07 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SOAP / TOPICAL | 0.85 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | LOTION / TOPICAL | 25 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | EMULSION / TOPICAL | 7.8 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT, AUGMENTED / TOPICAL | 81.94 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 75a8b67a-fe09-40a6-b6e7-3eb1c821960f | 45b1c4da-11ac-4e3a-8c77-0b0cdb78df24 | 2024-10-01 | Warnings | 45b1c4da-11ac-4e3a-8c77-0b0cdb78df24 |
Adverse event summaries are temporarily unavailable. Other product information remains available.